Immunoconjugates and bispecific antibodies: Trends in therapeutic success and commercial focus
Drug Discovery Today(2023)
摘要
•Immunoconjugates and bispecific antibodies are rapidly gainin in popularity.•Most immunoconjugates and bsAbs are developed for the treatment of cancer.•A trend towards fast-followers is occurring for immunoconjugates and bsAbs.•The number of organizations developing these therapeutics is expanding rapidly.
更多查看译文
关键词
monoclonal antibodies,clinical trials,bispecific,antibody–drug conjugate
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要